Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I M Ghobrial

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Cancer Drug Targets|September 22, 2011
Anti-angiogenic therapies in the treatment of Waldenstrom's MacroglobulinemiaA Sacco, I M Ghobrial, A M Roccaro
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Waldenström's macroglobulinemia: a clinical perspective in the era of novel therapeuticsM A Dimopoulos, E Kastritis, I M Ghobrial
Journal of Biomedicine & Biotechnology|October 25, 2012
Bone marrow microenvironment in multiple myeloma progressionS Manier, A Sacco, X Leleu, et al.
Leukemia|February 23, 2018
Targeting MYC in multiple myelomaK K Jovanović, C Roche-Lestienne, I M Ghobrial, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2019
Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicineI S Batth, A Mitra, S Manier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicineI S Batth, A Mitra, S Manier, et al.
Leukemia|December 6, 2012
The influence of hypoxia on CML trafficking through modulation of CXCR4 and E-cadherin expressionA K Azab, E Weisberg, I Sahin, et al.
Leukemia|December 21, 2011
Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinibE Weisberg, A K Azab, P W Manley, et al.
Leukemia|September 11, 2009
The use of novel agents in the treatment of relapsed and refractory multiple myelomaJ P Laubach, A Mahindra, C S Mitsiades, et al.
Blood Cancer Journal|April 29, 2014
Distinct roles of class I PI3K isoforms in multiple myeloma cell survival and disseminationI Sahin, M Moschetta, Y Mishima, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Cancer Drug Targets|September 22, 2011
Anti-angiogenic therapies in the treatment of Waldenstrom's MacroglobulinemiaA Sacco, I M Ghobrial, A M Roccaro
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Waldenström's macroglobulinemia: a clinical perspective in the era of novel therapeuticsM A Dimopoulos, E Kastritis, I M Ghobrial
Journal of Biomedicine & Biotechnology|October 25, 2012
Bone marrow microenvironment in multiple myeloma progressionS Manier, A Sacco, X Leleu, et al.
Leukemia|February 23, 2018
Targeting MYC in multiple myelomaK K Jovanović, C Roche-Lestienne, I M Ghobrial, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2019
Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicineI S Batth, A Mitra, S Manier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicineI S Batth, A Mitra, S Manier, et al.
Leukemia|December 6, 2012
The influence of hypoxia on CML trafficking through modulation of CXCR4 and E-cadherin expressionA K Azab, E Weisberg, I Sahin, et al.
Leukemia|December 21, 2011
Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinibE Weisberg, A K Azab, P W Manley, et al.
Leukemia|September 11, 2009
The use of novel agents in the treatment of relapsed and refractory multiple myelomaJ P Laubach, A Mahindra, C S Mitsiades, et al.
Blood Cancer Journal|April 29, 2014
Distinct roles of class I PI3K isoforms in multiple myeloma cell survival and disseminationI Sahin, M Moschetta, Y Mishima, et al.
Pageof 2